EUVIMEDOtkrijte EUVIMED
EUVIMED · CrossrefJournal

Clinical & Experimental Metastasis

ISSN 0262-0898 · Springer Science and Business Media LLC

Latest articles

  1. Metastasis-directed stereotactic radiotherapy in patients with breast cancer: results of an international multicenter cohort study

    Alexander Fabian, Daniel Buergy, Fabian Weykamp, Juliane Hörner-Rieber, Denise Bernhardt, Judit Boda-Heggemann, Montserrat Pazos, Nora Mehrhof, David Kaul, Alicia S. Bicu, Eugenia Vlaskou Badra, Susanne Rogers, Stefan Janssen, Hossein Hemmatazad, Katharina Hintelmann, Eleni Gkika, Tim Lange, Konstantinos Ferentinos, Heiko Karle, Thomas Brunner, Andrea Wittig, Marciana Nona-Duma, Oliver Blanck, David Krug

    Published: 2025-02DOI: 10.1007/s10585-024-10326-x

  2. Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2

    Levent Mutlu, Blair McNamara, Stefania Bellone, Diego D. Manavella, Cem Demirkiran, Michelle Greenman, Miguel Skyler Z. Verzosa, Natalia Buza, Pei Hui, Tobias Max Philipp Hartwich, Justin Harold, Yang Yang-Hartwich, Margherita Zipponi, Gary Altwerger, Elena Ratner, Gloria S. Huang, Mitchell Clark, Vaagn Andikyan, Masoud Azodi, Peter E. Schwartz, Alessandro D. Santin

    Published: 2024-10DOI: 10.1007/s10585-024-10297-z

Volumes

2025 · 92024 · 842023 · 442022 · 762021 · 502020 · 652019 · 462018 · 732017 · 502016 · 712015 · 672014 · 812013 · 912012 · 892011 · 702010 · 592009 · 932008 · 932007 · 672006 · 302005 · 882004 · 652003 · 882002 · 862000 · 881999 · 1081998 · 801997 · 621996 · 821995 · 551994 · 521993 · 551992 · 731991 · 471990 · 551989 · 591988 · 471987 · 311986 · 291985 · 25

Znanje koje odgovara vašem radu.

Od besplatnog početka i osobnog pretraživanja literature do potpunog paketa Research Suite.

Prikaži tarife →

Jesu li uključeni svi cjeloviti tekstovi izdavača?

Ne. Bibliografski zapisi, sažeci i cjeloviti tekstovi različiti su sadržaji. Hoće li cjeloviti tekst biti dostupan ovisi o izvoru, Open Accessu i vašim postojećim licencama. Tarifa EUVIMED ne zamjenjuje dodatna izdavačka prava.